Both in Biotechnology
Atara Biotherapeutics vs Anavex Life Sciences
Over the past year ATRA returned −37.8% and AVXL returned −84.3%; their daily moves had a correlation of 0.02.
ATRA −37.8% AVXL −84.3%Growth of $1, one year, split-adjusted
| Metric | ATRA | AVXL |
|---|---|---|
| Price | $8.62 | $1.22 |
| Market cap | $86.5M | $112.6M |
| Today | +1.65% | +6.58% |
| 1 month | −8.3% | −26.1% |
| 6 months | +81.1% | −63.8% |
| Year to date | −52.3% | −65.9% |
| 1 year | −42.0% | −84.8% |
| Revenue growth (YoY) | −96.4% | — |
| Gross margin | 69.7% | — |
| Net margin | −767.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 14.0× | — |
| Net cash | $9.9M | $118.3M |
| Dividend yield | — | — |
| Volatility (60d) | 65.2% | 74.5% |
| Short % of float | 11.2% | 14.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).